advertisement
9
Specifications
Patient Population
The Welch Allyn Spot Vital Signs is designed for use with adult and pediatric patients.
Welch Allyn defines a pediatric patient as 29 days or more of age.
THE WELCH ALLYN SPOT VITAL SIGNS IS NOT INTENDED FOR USE ON NEONATES
.
Welch Allyn defines neonates as children 28 days or less of age, born at term (37 weeks gestation or more), otherwise up to 44 gestational weeks.
Blood Pressure
Cuff Pressure Range
Cuff Inflation Factory
Default
Systolic Range
Diastolic Range
Accuracy
Determination Time
Pulse Rate Range
Pulse Rate Accuracy
Overpressure Cutoff
0 mmHg to 300 mmHg
160 mmHg
60 mmHg to 250 mmHg
30 mmHg to 160 mmHg
Blood pressure accuracy meets or exceeds SP10-1992 AAMI standards for non-invasive blood pressure accuracy (AAMI standard: ± 5 mmHg mean error,
8 mmHg standard deviation). Blood pressure accuracy is validated for pressure measurement using the upper arm only.
Typical: 20 to 45 seconds
Maximum: 165 seconds
40 bpm to 200 bpm
±5.0%
305 mmHg -0/+15 mmHg
Temperature
Accuracy
Range
Determination Time
Calibration accuracy: + 0.2° F (+ 0.1° C).
Maximum: 109.4° F/43.0° C
Minimum:
86.0° F/30.0° C
Oral: approximately 4 seconds
Axillary: approximately 10 seconds
Rectal: approximately 15 seconds
43
44
Welch Allyn Spot Vital Signs
Pulse Oximetry
Masimo Sensor Accuracy Guide
Accuracy specified when used with Masimo SET pulse oximetry monitors or with licensed Masimo SET pulse oximetry modules using Masimo patient cables, during no motion. Numbers present ± 1 standard deviation. Plus or minus one standard deviation represents 68% of the population. SpO
2
accuracy from 70% to 100%. Pulse rate accuracy from 25 to 240 bpm.
Performance Measurement Range
Perfusion
SpO
2
Accuracy
Pulse Rate Accuracy
SpO
2
: 70 to 100%
Pulse Rate: 25 - 240 beats per minute (BPM)
0.02% to 20%
Saturation: 70% to 100%
No Motion: Adults, Pediatrics ± 2 digits
Motion: Adults, Pediatrics ± 3 digits
Low Perfusion: Adults, Pediatrics ± 2 digits
Pulse Rate: 25 to 240 bpm
No Motion: Adults and Pediatrics ± 3 digits
Motion: Adults and Pediatrics ± 5 digits
Low Perfusion: Adults and Pediatrics ± 3 digits
Table 14. Masimo Sensor Accuracy Guide
Sensor
LNCS-DCI
LNCS-DCIP
LNCS-ADTX
LNCS-PDTX
LNCS INF-L
LNOP-DCI
LNOP-DCIP
LNOP-ADT
LNOP-PDT
LNOP INF-L
Weight Range
> 30 kg
10 to 50 kg
> 30 kg
10 to 50 kg
3 to 20 kg
> 30 kg
10 to 50 kg
> 30 kg
10 to 50 kg
3 to 20 kg
Saturation Accuracy
No Motion
± 2%
± 2%
± 2%
± 2%
± 2%
± 2%
± 2%
± 2%
± 2%
± 2%
Motion
± 3%
± 3%
± 3%
± 3%
± 3%
± 3%
± 3%
± 3%
± 3%
± 3%
Pulse Rate Accuracy
No Motion
± 3 bpm
± 3 bpm
± 3 bpm
± 3 bpm
± 3 bpm
± 3 bpm
± 3 bpm
± 3 bpm
± 3 bpm
± 3 bpm
Motion
± 5 bpm
± 5 bpm
± 5 bpm
± 5 bpm
± 5 bpm
± 5 bpm
± 5 bpm
± 5 bpm
± 5 bpm
± 5 bpm
Masimo Patents
The Masimo sensors and cables are covered under one or more of the following U.S.A. patents: 5,758,644; 5,823,950; 6,011,986; 6,157,850; 6,263,222; 6,501,975; and other applicable patents listed at www.masimo.com/patents.htm.
Directions for Use
45
Nellcor
®
Sensor Accuracy Guide
Accuracy specifications are based on controlled hypoxia studies with healthy, non-smoking adult volunteers over the specified saturation SpO
2 range. Pulse oximeter
SpO
2
readings were compared to SaO
2 values of drawn blood samples measured by hemoximetry. All accuracies are expressed as + “X” digits. This variation equals plus one standard deviation (+ 1 SD), which encompasses 68% of the population.
Pulse Rate Range
Pulse Rate Accuracy
25 to 240 bpm
±3 bpm
±3 bpm (low perfusion)
Table 15. OxiMax Sensor Models, Single Patient Use
Sensor Models
MAX-AI
MAX-PI
MAX-II
MAX-RI
1
1
The accuracy specification has been determined between saturations of 80% to 100%.
SpO
2
Range
70% to 100%
± 2
± 2
± 2
± 3.5
Table 16. OxiCliq Sensor Models, Single Patient Use
Sensor Models
OXICLIQ-PI
SpO
2
Range
70% to 100%
± 2.5
Table 17. Reusable Sensor Models
Sensor Models
D-YS (Infant to Adult)
D-YS and D-YSE
D-YS and D-YSPD
DS-100A
OXI-A/N (Adult)
OXI-P/I (Pediatric/infant)
SpO
2
Range
70% to 100%
± 3
± 3.5
± 3.5
± 3
Adult: ± 3
± 3
Nellcor Patents
Covered by one or more of the following US Patents: 4,802,486; 4,869,254; 4,928,692;
4,934,372; 5,078,136; 5,351,685; 5,485,847; 5,533,507; 5,577,500; 5,803,910; 5,853,364;
5,865,736; 6,083,172; 6,708,049; Re. 35,122 and foreign equivalents.
46
Welch Allyn Spot Vital Signs
Mechanical
Dimensions
Weight
Mounting
Height: 9.7 inches (24.6 cm)
Length: 5.7 inches (14.5 cm)
Depth: 4.7 inches (12.0 cm)
Approximately 4.6 pounds (2.2 kg)
Self-supporting on rubber feet
Custom Mobile Stand
Custom Wall Mount
Custom IV Pole Mount
May be hand-carried when held by the rear handle.
Portability
Electrical
Power Requirements
Battery
Patient-rated isolation transformer is connected to AC mains:
North American Version:120VAC, 60Hz. 0.13A Input, 7.2VDC, 1.0A Output
International Version:240VAC, 50Hz 0.065A Input, 7.2VDC, 1.0A Output
Australian Version:240VAC, 50Hz, 13VA Input, 7.2VDC, 1.0A Output
Lead acid, with external charger.
A fully charged battery supports 130 typical blood pressure determinations taken at
7-minute intervals. The battery is 90-100% charged after 12 hours of charging. The battery automatically charges when the Spot Vital Signs is powered through the AC power transformer. The battery charges faster when the instrument is not in operation.
Environmental
Operating Temperature
Storage Temperature
Transport Temperature
Relative Humidity
Operating Altitude
+10
°
to +40
°
C (Thermometer operating temperature 16° to 40° C)
+50
°
to +104
°
F (Thermometer operating temperature 61° to 104° F)
-20
°
to +50
°
C
-4
°
to +122
°
F
-20
°
to +49
°
C
-4
°
to +122
°
F
15 to 90% (non-condensing)
-170 to +4877 m
-557 to +16,000 ft.
Directions for Use
Guidance and Manufacturer’s Declaration
Emissions and Immunity Information
Electromagnetic Emissions
The 420 Series Spot Vital Signs is intended for use in the electromagnetic environment specified below. The customer or user of the 420 Series
Spot Vital Signs should assure that it is used in such an environment.
Emissions Test
RF emissions
CISPR 11
RF emissions
CISPR 11
Harmonic emissions
IEC 61000-3-2
Voltage fluctuations/ flicker emissions
IEC 61000-3-3
Compliance
Group 1
Class B
Class A
Complies
Electromagnetic Environment - Guidance
The 420 Series Spot Vital Signs uses RF energy only for its internal function. Therefore, its RF emissions are very low and are not likely to cause any interference in nearby electronic equipment.
The 420 Series Spot Vital Signs is suitable for use in all establishments, including domestic establishments and those directly connected to the public low-voltage power supply network that supplies buildings used for domestic purposes.
47
48
Welch Allyn Spot Vital Signs
Electromagnetic Immunity
The 420 Series Spot Vital Signs is intended for use in the electromagnetic environment specified below. The customer or user of the 420 Series
Spot Vital Signs should assure that it is used in such an environment.
Immunity Test IEC 60601
Test Level
± 6 kV contact Electrostatic discharge
(ESD)
± 8 kV air
IEC 61000-4-2
Electrical fast transient/ burst
±2 kV for power supply lines
Compliance Level
± 6 kV contact
± 8 kV air
±2 kV for power supply lines
Electromagnetic Environment - Guidance
Floors should be wood, concrete, or ceramic tile. If floors are covered with synthetic material, the relative humidity should be at least 30%.
Mains power quality should be that of a typical commercial or hospital environment.
IEC 61000-4-4
Surge
IEC 61000-4-5
Voltage dips, short interruptions, and voltage variations on power supply input lines.
IEC 61000-4-11
Power frequency
(50/60Hz) magnetic field
IEC 61000-4-8
±1 kV for input/output lines
±1 kV differential mode
±1 kV for input/output lines
±1 kV differential mode Mains power quality should be that of a typical commercial or hospital environment.
±2 kV common mode
>95% dip in 0.5 cycle
±2 kV common mode
>95% dip in 0.5 cycle
60% dip in 5 cycles
30% dip for 25 cycles
60% dip in 5 cycles
30% dip for 25 cycles
Mains power quality should be that of a typical commercial or hospital environment. If the user of the 420 Series Spot Vital
Signs requires continued operation during power mains interruptions, it is recommended that the 420 Series Spot Vital
Signs be powered from an uninterruptible power supply or battery.
>95% dip in 5 seconds
3 A/m
>95% dip in 5 seconds
3 A/m Power frequency magnetic fields should be at levels characteristic of a typical location in a typical commercial or hospital environment.
Directions for Use
49
Electromagnetic Immunity
The 420 Series Spot Vital Signs is intended for use in the electromagnetic environment specified below. The customer or user of the 420 Series
Spot Vital Signs should assure that it is used in such an environment.
Immunity Test IEC 60601
Test Level
Conducted RF
IEC 61000-4-6
Radiated RF
IEC 61000-4-3
3 Vrms
150 kHz to 80 MHz
3 V/m
80 MHz to 2.5 GHz
Compliance
Level
Electromagnetic Environment - Guidance
Portable and mobile RF communications equipment should be used no closer to any part of the 420 Series Spot Vital Signs including cables, than the recommended separation distance calculated from the equation applicable to the frequency of the transmitter.
Recommended separation distance
V1 = 3 Vrms
d
= (1.17)
P
E1 = 3 V/m
d
= (1.17)
P
80 MHz to 800 MHz
d
= (2.33)
P
800 MHz to 2.5 GHz where
P
is the maximum output power rating of the transmitter in watts (W) according to the transmitter manufacturer and
d
is the recommended separation distance in metres (m).
Field strengths from fixed RF transmitters, as determined by an electromagnetic site survey, a
should be less than the compliance level in each frequency range.
b
Interference may occur in the vicinity of equipment marked with the following symbol:
Note 1: At 80 MHz and 800 MHz, the higher frequency range applies.
Note 2: These guidelines may not apply in all situations. Electromagnetic propagation is affected by absorption and reflection from structures, objects, and people.
a
Field strengths from fixed transmitters, such as base stations for radio (cellular/cordless) telephones and land mobile radios, amateur radio,
AM and FM radio broadcast and TV broadcast cannot be predicted theoretically with accuracy. To assess the electromagnetic environment due to fixed RF transmitters, an electromagnetic site survey should be considered. If the measured field strength in the location in which the 420
Series Spot Vital Signs is used exceeds the applicable RF compliance level above, the 420 Series Spot Vital Signs should be observed to verify normal operation. If abnormal performance is observed, additional measures may be necessary, such as reorienting or relocating the 420 Series
Spot Vital Signs.
b
Over the frequency range 150 kHz to 80 MHz, field strengths should be less than 3 V/m.
50
Welch Allyn Spot Vital Signs
Recommended Separation Distances Between Portable and Mobile RF Communications Equipment and the 420 Series Spot
Vital Signs
The 420 Series Spot Vital Signs is intended for use in an electromagnetic environment in which radiated RF disturbances are controlled. The customer or user of the 420 Series Spot Vital Signs can help prevent electromagnetic interference by maintaining a minimum distance between portable and mobile RF communications equipment (transmitters) and the 420 Series Spot Vital Signs as recommended below, according to the maximum output power of the communications equipment.
Rated Max. Output
Power of Transmitter
(W)
0.01
0.1
1
10
100
Separation Distance According to Frequency of Transmitter (m)
150 kHz to 80 MHz 80 MHz to 800 MHz 800 MHz to 2.5 GHz
d
= (1.17)
P
0.11667
0.36894
1.1667
3.6894
11.667
d
= (1.17)
0.11667
0.36894
1.1667
3.6894
11.667
P
d
= (2.33)
0.23333
0.73785
2.3333
7.3785
23.333
P
For transmitters rated at a maximum output power not listed above, the recommended separation distance
d
in meters (m) can be estimated using the equation applicable to the frequency of the transmitter, where
P
is the maximum output power rating of the transmitter in watts (W) according to the transmitter manufacturer.
Note 1: At 80 MHz and 800 MHz, the separation distance for the higher frequency range applies.
Note 2: These guidelines may not apply in all situations. Electromagnetic propagation is affected by absorption and reflection from structures, objects, and people.
Directions for Use
Patents
D392,043 and other patents pending.
Agency Approvals
CERTIFIED TO: CAN/CSA STD C22.2 NO. 601.1
CONFORMS TO: IEC 60601, UL STD 60601-1
Welch Allyn PTY, Ltd - Australia
Metro Centre
Unit 5/38 South Street
Rydalmere NSW 2116, Australia
EMC Framework of Australia
The CE mark on this product indicates that it has been tested to and conforms with the provisions noted within the 93/42/
EEC Medical Device Directive.
EC REP
Authorized European Representative Address:
European Regulatory Manager
Welch Allyn Ltd.
Navan Business Park
Dublin Road
Navan, County Meath, Republic of Ireland
Tel.: +353 46 90 67700 • Fax: +353 46 90 67756
51
52
Welch Allyn Spot Vital Signs
advertisement
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Related manuals
advertisement
Table of contents
- 1 Welch Allyn Spot Vital Signs
- 3 Welch Allyn Spot Vital Signs
- 5 Configuration
- 9 Introduction
- 9 Product Overview
- 10 Related Publications
- 10 Indications/Contraindications for Use
- 11 Symbols and Descriptions
- 11 IPXØ
- 12 Safety Warnings and Cautions
- 12 General Warnings
- 13 Blood Pressure Warnings
- 14 SpO2 Warnings
- 15 Temperature Warnings
- 15 IR Communications Port Warnings
- 15 General Cautions
- 16 Blood Pressure Cautions
- 16 SpO2 Cautions
- 16 Temperature Cautions
- 17 Avertissements et précautions de sécurité
- 17 Avertissements généraux
- 18 Avertissements relatifs à la pression artérielle
- 19 Avertissements relatifs à SpO2
- 20 Avertissements relatifs à la température
- 20 Avertissements relatifs au port de communication infrarouge
- 20 Précautions générales
- 21 Précautions relatives à la pression artérielle
- 21 Précautions relatives à SpO2
- 21 Précautions relatives à la température
- 23 Controls, Indicators, and Connections
- 23 Unpacking Checklist
- 23 Possible Attachments
- 24 Front Panel Functions
- 25 LCD (Liquid Crystal Display)
- 26 Top, Side, and Rear Panel Connections
- 27 Internal Configuration
- 29 Setup
- 29 Blood Pressure Hose and Cuff Connections
- 29 Temperature Probe Connection
- 29 SpO2 Sensor Connection
- 30 Quick Reference/Error Code Card
- 30 AC Power Connection
- 30 Charging the Battery
- 30 Standby Mode
- 31 Blood Pressure
- 31 Selecting the Blood Pressure Cuff
- 31 Determining Blood Pressure Cuff Size with the Markings
- 31 Chart for Determining Blood Pressure Cuff Size
- 33 Reviewing Information from the Last Cycle
- 34 Checking the Blood Pressure Calibration
- 37 Temperature
- 37 Selecting Temperature Operation Mode
- 37 Temperature Measurement Range Indicators
- 37 Normal Mode
- 41 Monitor Mode
- 43 Pulse Oximetry (Sp02)
- 45 Error Indications and Interpretation
- 45 Error Codes
- 47 Causes and Corrective Action
- 51 Specifications
- 51 Patient Population
- 51 Blood Pressure
- 51 Temperature
- 52 Pulse Oximetry
- 52 Masimo Sensor Accuracy Guide
- 52 Masimo Patents
- 53 Nellcor® Sensor Accuracy Guide
- 53 Nellcor Patents
- 54 Mechanical
- 54 Electrical
- 54 Environmental
- 55 Guidance and Manufacturer’s Declaration
- 55 Emissions and Immunity Information
- 59 Patents
- 59 Agency Approvals
- 61 Maintenance
- 61 Cleaning
- 61 Spot Vital Signs
- 61 Blood Pressure Cuff
- 62 Cables and Pressure Hose
- 62 Temperature Probe
- 62 SpO2 Sensor
- 62 Battery Removal and Replacement
- 63 Masimo SpO2 Calibration Check
- 63 Nellcor SpO2 Functional Check
- 63 SpO2 Accessory Disposal
- 63 Temperature Calibration Check
- 64 Service Manual/Spare Parts
- 64 Service Loaners
- 64 Service Policy
- 64 Technical Assistance
- 65 Supplies and Accessories
- 65 Latex-Free Blood Pressure
- 66 Pulse Oximetry Accessories and Supplies
- 66 Masimo
- 67 Nellcor
- 68 Temperature
- 68 Mounting
- 68 Extended Warranty
- 69 Miscellaneous
- 71 Warranty
- 71 Spot
- 71 Accessories